Changing mortality rates and causes of death for HIV-infected individuals living in Southern Alberta, Canada from 1984 to 2003

HIV Medicine

Volumn 6, Issue 2, 2005, Pages 99-106

  Krentz, Hartmut B ^a,b   Kliewer, G ^c   Gill, M J ^a,b  

^a Southern Alberta Clinic   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

^c CALGARY HEALTH REGION   (Canada)

Author keywords

Causes of death; HIV AIDS; Mortality rates; Non HIV related deaths

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AGE DISTRIBUTION; ARTICLE; CANADA; CANCER; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; CIGARETTE SMOKING; CLINICAL FEATURE; COMORBIDITY; CONTROLLED STUDY; DEATH CERTIFICATE; DEMOGRAPHY; DISEASE COURSE; DRUG FATALITY; DRUG OVERDOSE; DRUG TOLERABILITY; DYING; FACTUAL DATABASE; GEOGRAPHIC DISTRIBUTION; HEPATITIS B; HEPATITIS C; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERNATIONAL CLASSIFICATION OF DISEASES; INTRAVENOUS DRUG ABUSE; LIVER DISEASE; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MEDICAL DOCUMENTATION; MORTALITY; MULTIDRUG RESISTANCE; MYCOBACTERIOSIS; MYCOBACTERIUM INTRACELLULARE AVIUM; NONHODGKIN LYMPHOMA; PNEUMOCYSTIS PNEUMONIA; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PUBLIC HEALTH; SUICIDE; T LYMPHOCYTE; TREATMENT FAILURE; VIOLENCE;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ALBERTA; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; ANTIVIRAL AGENTS; CAUSE OF DEATH; DISEASE PROGRESSION; DRUG RESISTANCE, MULTIPLE, VIRAL; HIV INFECTIONS; HUMANS; LYMPHOMA, NON-HODGKIN; MYCOBACTERIUM AVIUM-INTRACELLULARE INFECTION; PNEUMONIA, PNEUMOCYSTIS; SOCIOECONOMIC FACTORS; SUBSTANCE ABUSE, INTRAVENOUS; TREATMENT REFUSAL;

EID: 15844379887     PISSN: 14642662     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1468-1293.2005.00271.x     Document Type: Article

References (22)

1. Pallella FJ Jr, Delancy KM, Moorman AC et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med 1998; 338: 853-860.
2. Jain MK, Skiest DJ, Cloud JW, Jain CL, Burn D, Berggren RE. Changes in mortality related to human immunodeficiency virus infection: comparative analysis of inpatient deaths in 1995 and in 1999-2000. Clin Inf Dis (CID) 2003; 36: 1030-1038.
3. Schanzer DL. HIV/AIDS mortality in trends in Canada, 1987-1998. Can J Public Health 2003; 94: 135-139.
4. Mocroft A, Ledergerber B, Katlama C et al. Decline in the AIDS and death rates in the EuroSIDA study: an observational study. Lancet 2003; 362: 22-29.
5. Van Sighem AI, van de Wiel MA, Ghani AC et al. Mortality and progression to AIDS after starting highly active antiretroviral therapy. AIDS 2003; 17: 2227-2236.
6. Hogg RS, O'Shaughnessy MV, Gataric N et al. Decline in deaths from AIDS due to new antiretrovirals. Lancet 1997; 349 1294.
7. Porter K, Babiker A, Bhaskaran K et al. Determinants of survival following HIV-1 seroconversion after the introduction of HAART. Lancet 2003; 362: 1267-1274.
8. Messeri P, Lee G, Abramson DM, Aidala A, Chiasson MA, Jessop DJ. Antiretroviral therapy and declining AIDS mortality in New York City. Med Care 2003; 41: 512-521.
9. Schanzer DL. Trends in HIV/AIDS mortality in Canada, 1987-1998. Can J Public Health 2003, 94: 135-139.
10. Rodriquez BV, Valdez H, Salata H et al. Changes in causes of death in a cohort of HIV-infected individuals: analysis of the last 6 years. Programs and Abstracts of the 9th Conference on Retroviruses and Opportunistic Infections. Seattle, WA, February 2002 [Abstract 755-W].
11. Palella FJ Jr, Baker R, Moorman AC, Chmiel J, Wood K. Holmberg SD and the HOPS Investigators. Mortality and morbidity in the HAART era: changing causes of death and disease in the HIV Outpatient Study. Programs and Abstracts of the 11th Conference on Retroviruses and Opportunistic Infections. San Francisco, CA, February 2004 [Abstract 872].
12. Rimland D, Guest J. Mortality in the HIV Atlanta VA Cohort Study: a 22-year analysis. Programs and Abstracts of the 11th Conference on Retroviruses and Opportunistic Infections. San Francisco, CA, February 2004 [Abstract 873].
13. Bonnet F, Lewden C, May D et al. Malignancies-related causes of death of HIV-infected patients in the era of highly active antiretroviral therapy. Programs and Abstracts of the 11th Conference on Retroviruses and Opportunistic Infections. San Francisco, CA, February 2004 [Abstract 875].
14. Wolfe MI, Hanson DL, Selik DL, Swerdlow R. Deaths from non-AIDS related diseases have increased as a proportion of deaths of HIV-infected persons since the advent of HAART. Programs and Abstracts of the 9th Conference on Retroviruses and Opportunistic Infections. Seattle, WA, February 2002 [Abstract 14].
15. Jambroes MD, Dieleman J, van de Wiel J et al. Changing mortality in an HIV-infected population on HAART. Programs and Abstracts of the 9th Conference on Retroviruses and Opportunistic Infections. Seattle, WA, February 2002 [Abstract 754-W].
16. Selik R, Singh T, Hsu L. The proportion of deaths due to HIV infection among persons with AIDS in New York City and San Francisco during 1987 and 1999. Programs and Abstracts of the 11th Conference on Retroviruses and Opportunistic Infections. San Francisco, CA, February 2004 [Abstract 871].
17. Wood E, Montaner JSG, Tyndall MW, Schecheter MT, O'Shaughnessy MV, Hogg RS. Prevalence and correlates of untreated human immunodeficiency virus type 1 infection among persons who have died in the era of modern antiretroviral therapy. J Inf Dis (JID) 2003; 188: 1164-1170.
18. Sabin C. The changing clinical epidemiology of AIDS in the highly active antiretroviral therapy era. AIDS 2002; 16: S61-S68.
19. Knodel J, Van Landingham M. The impact of the AIDS epidemic on older persons. AIDS 2002; 16: S77-S83.
20. Haydon GH, Mutimer DJ. Hepatitis B and C virus infections in the immune compromised. Curr Opin Infect Dis 2003; 16: 473-479.
21. Clarke CA, Glaser SL. Epidemiologic trends in HIV-associated lymphomas. Curr Opin Infect Dis 2001; 13: 354-359.
22. Chiao EY, Krown SE. Update on non-acquired immunodefiency syndrome-defining malignancies. Curr Opin Infect Dis 2003; 15 389-397.